Estrogen receptor β selective nonsteroidal estrogens: seeking clinical indications

Bibliography

• Tsai MJ, O'Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 1994;63:451-86
   PubMed Web of Science ®Google Scholar
• Sonoda J, Pei L, Evans RM. Nuclear receptors: decoding metabolic disease. FEBS Lett 2008;582(1):2-9
   PubMed Web of Science ®Google Scholar
• Evans RM. The steroid and thyroid hormone receptor superfamily. Science 1988;240(4854):889-95
   PubMedGoogle Scholar
• Segal S, Narayanan R, Dalton JT. Therapeutic potential of the SARMs: revisiting the androgen receptor for drug discovery. Expert Opin Investig Drugs 2006;15(4):377-87
   PubMedGoogle Scholar
• Lofthouse S, Snibson K. Claims of current inhaled corticosteroid patents for treating asthma. Recent Pat Inflamm Allergy Drug Discov 2007;1(2):146-50
   PubMedGoogle Scholar
• Forman BM, Chen J, Evans RM. The peroxisome proliferator-activated receptors: ligands and activators. Ann NY Acad Sci 1996;804:266-75
   PubMed Web of Science ®Google Scholar
• Lindsay R, Gallagher JC, Kagan R, Efficacy of tissue-selective estrogen complex of bazedoxifene/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women. Fertil Steril 2009;92(3):1045-52
   PubMedGoogle Scholar
• Cronin M, Schellschmidt I, Dinger J. Rate of pregnancy after using drospirenone and other progestin-containing oral contraceptives. Obstet Gynecol 2009;114(3):616-22
   PubMedGoogle Scholar
• Gillatt D. Antiandrogen treatments in locally advanced prostate cancer: are they all the same? J Cancer Res Clin Oncol 2006;132(Suppl 1):S17-26
   Google Scholar
• Ottow E, Weinmann H. Nuclear Receptors as Drug Targets. Weinheim, Germany: Wiley-VCH; 2008
   Google Scholar
• Dodds EC, Lawson W. Synthetic oestrogenic agents without a phenanthrene nucleus. Nature 1936;137:56
   Google Scholar
• Jensen EV, Jacobson HI. Basic guides to the mechanism of estrogen action. Rec Prog Horm Res 1962;18:387-414
   Google Scholar
• Greene GL, Gilna P, Waterfield M, Sequence and expression of human estrogen receptor complementary DNA. Science 1986;231(4742):1150-4
   PubMedGoogle Scholar
• Green S, Walter P, Kumar V, Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 1986;320(6058):134-9
   PubMedGoogle Scholar
• Kuiper GG, Enmark E, Pelto-Huikko M, Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996;93(12):5925-30
   PubMedGoogle Scholar
• Lubahn DB, Moyer JS, Golding TS, Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc Natl Acad Sci USA 1993;90(23):11162-6
   PubMedGoogle Scholar
• Couse JF, Curtis SW, Washburn TF, Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene. Mol Endocrinol 1995;9(11):1441-54
   PubMedGoogle Scholar
• Couse JF, Korach KS. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 1999;20(3):358-417
   PubMedGoogle Scholar
• Curtis Hewitt S, Couse JF, Korach KS. Estrogen receptor transcription and transactivation: Estrogen receptor knockout mice: what their phenotypes reveal about mechanisms of estrogen action. Breast Cancer Res 2000;2(5):345-52
   PubMedGoogle Scholar
• Deroo BJ, Korach KS. Estrogen receptors and human disease. J Clin Invest 2006;116(3):561-70
   PubMedGoogle Scholar
• Kuiper GG, Carlsson B, Grandien K, Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997;138(3):863-70
   PubMed Web of Science ®Google Scholar
• Shughrue PJ, Lane MV, Scrimo PJ, Merchenthaler I. Comparative distribution of estrogen receptor-alpha (ER-alpha) and beta (ER-beta) mRNA in the rat pituitary, gonad, and reproductive tract. Steroids 1998;63(10):498-504
   PubMedGoogle Scholar
• Veeneman GH. Non-steroidal subtype selective estrogens. Curr Med Chem 2005;12(9):1077-136
   PubMedGoogle Scholar
• Nishihara E, Nagayama Y, Inoue S, Ontogenetic changes in the expression of estrogen receptor alpha and beta in rat pituitary gland detected by immunohistochemistry. Endocrinology 2000;141(2):615-20
   PubMedGoogle Scholar
• Shupnik MA. Oestrogen receptors, receptor variants and oestrogen actions in the hypothalamic-pituitary axis. J Neuroendocrinol 2002;14(2):85-94
   PubMedGoogle Scholar
• Dupont S, Krust A, Gansmuller A, Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development 2000;127(19):4277-91
   PubMedGoogle Scholar
• Krege JH, Hodgin JB, Couse JF, Generation and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci USA 1998;95(26):15677-82
   PubMedGoogle Scholar
• Shughrue PJ, Askew GR, Dellovade TL, Merchenthaler I. Estrogen-binding sites and their functional capacity in estrogen receptor double knockout mouse brain. Endocrinology 2002;143(5):1643-50
   PubMedGoogle Scholar
• Harris HA. Estrogen receptor-beta: recent lessons from in vivo studies. Mol Endocrinol 2007;21(1):1-13
   PubMedGoogle Scholar
• Windahl SH, Andersson G, Gustafsson JA. Elucidation of estrogen receptor function in bone with the use of mouse models. Trends Endocrinol Metab 2002;13(5):195-200
   PubMedGoogle Scholar
• Sanchez-Criado JE, Martin De Las Mulas J, Bellido C, Biological role of pituitary estrogen receptors ERalpha and ERbeta on progesterone receptor expression and action and on gonadotropin and prolactin secretion in the rat. Neuroendocrinology 2004;79(5):247-58
   PubMedGoogle Scholar
• Prins GS, Birch L, Couse JF, Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor alpha: studies with alphaERKO and betaERKO mice. Cancer Res 2001;61(16):6089-97
   PubMedGoogle Scholar
• Weihua Z, Makela S, Andersson LC, A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc Natl Acad Sci USA 2001;98(11):6330-5
   PubMedGoogle Scholar
• Cunha GR, Wang YZ, Hayward SW, Risbridger GP. Estrogenic effects on prostatic differentiation and carcinogenesis. Reprod Fertil Dev 2001;13(4):285-96
   PubMedGoogle Scholar
• Ricke WA, McPherson SJ, Bianco JJ, Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling. Faseb J 2008;22(5):1512-20
   PubMedGoogle Scholar
• McPherson SJ, Ellem SJ, Simpson ER, Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia. Endocrinology 2007;148(2):566-74
   PubMedGoogle Scholar
• Norman BH, Dodge JA, Richardson TI, Benzopyrans are selective estrogen receptor beta agonists with novel activity in models of benign prostatic hyperplasia. J Med Chem 2006;49(21):6155-7
   PubMedGoogle Scholar
• Catley MC, Birrell MA, Hardaker EL, Estrogen receptor beta: expression profile and possible anti-inflammatory role in disease. J Pharmacol Exp Ther 2008;326(1):83-8
   PubMedGoogle Scholar
• Cvoro A, Tatomer D, Tee MK, Selective estrogen receptor-beta agonists repress transcription of proinflammatory genes. J Immunol 2008;180(1):630-6
   PubMedGoogle Scholar
• Harris HA. Preclinical characterization of selective estrogen receptor beta agonists: new insights into their therapeutic potential. Ernst Schering Found Symp Proc 2006;(1):149-61
   PubMedGoogle Scholar
• Mewshaw RE, Edsall RJ Jr, Yang C, ERbeta ligands. 3. Exploiting two binding orientations of the 2-phenylnaphthalene scaffold to achieve ERbeta selectivity. J Med Chem 2005;48(12):3953-79
   PubMedGoogle Scholar
• Harris HA, Albert LM, Leathurby Y, Evaluation of an estrogen receptor-beta agonist in animal models of human disease. Endocrinology 2003;144(10):4241-9
   PubMedGoogle Scholar
• Harris HA, Bruner-Tran KL, Zhang X, A selective estrogen receptor-beta agonist causes lesion regression in an experimentally induced model of endometriosis. Hum Reprod 2005;20(4):936-41
   PubMedGoogle Scholar
• Dickson RB, Stancel GM. Estrogen receptor-mediated processes in normal and cancer cells. J Natl Cancer Inst Monogr 2000;2000(27):135-45
   Google Scholar
• Hartman J, Lindberg K, Morani A, Estrogen receptor beta inhibits angiogenesis and growth of T47D breast cancer xenografts. Cancer Res 2006;66(23):11207-13
   PubMedGoogle Scholar
• Wong NA, Malcomson RD, Jodrell DI, ERbeta isoform expression in colorectal carcinoma: an in vivo and in vitro study of clinicopathological and molecular correlates. J Pathol 2005;207(1):53-60
   PubMedGoogle Scholar
• Forster C, Makela S, Warri A, Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium. Proc Natl Acad Sci USA 2002;99(24):15578-83
   PubMedGoogle Scholar
• Gilad LA, Tirosh O, Schwartz B. Phytoestrogens regulate transcription and translation of vitamin D receptor in colon cancer cells. J Endocrinol 2006;191(2):387-98
   PubMedGoogle Scholar
• Motylewska E, Stasikowska O, Melen-Mucha G. The inhibitory effect of diarylpropionitrile, a selective agonist of estrogen receptor beta, on the growth of MC38 colon cancer line. Cancer Lett 2009;276(1):68-73
   Google Scholar
• Zhang G, Liu X, Farkas AM, Estrogen receptor beta functions through nongenomic mechanisms in lung cancer cells. Mol Endocrinol 2009;23(2):146-56
   PubMedGoogle Scholar
• Schrepfer S, Deuse T, Munzel T, The selective estrogen receptor-beta agonist biochanin A shows vasculoprotective effects without uterotrophic activity. Menopause 2006;13(3):489-99
   PubMedGoogle Scholar
• Yu HP, Shimizu T, Choudhry MA, Mechanism of cardioprotection following trauma-hemorrhagic shock by a selective estrogen receptor-beta agonist: up-regulation of cardiac heat shock factor-1 and heat shock proteins. J Mol Cell Cardiol 2006;40(1):185-94
   PubMedGoogle Scholar
• Ba ZF, Chaudry IH. Role of estrogen receptor subtypes in estrogen-induced organ-specific vasorelaxation after trauma-hemorrhage. Am J Physiol Heart Circ Physiol 2008;295(5):H2061-7
   Google Scholar
• Pelzer T, Loza PA, Hu K, Increased mortality and aggravation of heart failure in estrogen receptor-beta knockout mice after myocardial infarction. Circulation 2005;111(12):1492-8
   PubMedGoogle Scholar
• Otto C, Wessler S, Fritzemeier KH. Exploiting nongenomic estrogen receptor-mediated signaling for the Development of pathway-selective Estrogen receptor ligands. Ernst Schering Found Symp Proc 2006;(1):163-81
   PubMedGoogle Scholar
• Lonard DM, O'Malley BW. Nuclear receptor coregulators: judges, juries, and executioners of cellular regulation. Mol Cell 2007;27(5):691-700
   PubMed Web of Science ®Google Scholar
• Smith CL, O'Malley BW. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr Rev 2004;25(1):45-71
   PubMed Web of Science ®Google Scholar
• Madak-Erdogan Z, Kieser KJ, Kim SH, Nuclear and extranuclear pathway inputs in the regulation of global gene expression by estrogen receptors. Mol Endocrinol 2008;22(9):2116-27
   PubMedGoogle Scholar
• Ordonez-Moran P, Munoz A. Nuclear receptors: genomic and non-genomic effects converge. Cell Cycle 2009;8(11):1675-80
   PubMedGoogle Scholar
• Levin ER. Rapid signaling by steroid receptors. Am J Physiol Regul Integr Comp Physiol 2008;295(5):R1425-30
   Google Scholar
• Kousteni S, Chen JR, Bellido T, Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 2002;298(5594):843-6
   PubMedGoogle Scholar
• Song RX, Fan P, Yue W, Role of receptor complexes in the extranuclear actions of estrogen receptor alpha in breast cancer. Endocr Relat Cancer 2006;13(Suppl 1):S3-13
   PubMedGoogle Scholar
• Kumar R, Thompson EB. The structure of the nuclear hormone receptors. Steroids 1999;64(5):310-9
   PubMedGoogle Scholar
• Claessens F, Gewirth DT. DNA recognition by nuclear receptors. Essays Biochem 2004;40:59-72
   PubMed Web of Science ®Google Scholar
• Rolland Y, Abellan van Kan G, Benetos A, Frailty, osteoporosis and hip fracture: causes, consequences and therapeutic perspectives. J Nutr Health Aging 2008;12(5):335-46
   PubMedGoogle Scholar
• Klinge CM. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res 2001;29(14):2905-19
   PubMedGoogle Scholar
• Ascenzi P, Bocedi A, Marino M. Structure-function relationship of estrogen receptor alpha and beta: impact on human health. Mol Aspects Med 2006;27(4):299-402
   PubMedGoogle Scholar
• Ryan KJ. Editorial: cancer risk and estrogen use in the menopause. N Engl J Med 1975;293(23):1199-200
   PubMedGoogle Scholar
• Minutolo F, Bertini S, Granchi C, Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor beta. J Med Chem 2009;52(3):858-67
   PubMedGoogle Scholar
• Veeneman GH. Subtype-selective estrogens. In: Ottow E, Weinmann H, editor. Nuclear receptors as drug targets. Wiley-VCH; 2008. p. 71-87
   Google Scholar
• Redden PR. Selective Estrogen Receptor Modulators. Expert Opin Ther Patents 2004;14(3):337-53
   Google Scholar
• Ullrich JWaCPM. Estrogen receptor modulator review. Expert Opin Ther Patents 2006;16(5):559-72
   Google Scholar
• Manas ES, Mewshaw RE, Harris HA, Malamas M S. Chapter 8: isoform specificity: the design of estrogen receptor- beta selective compounds. In: Hubbard RE, editor, Structure-based drug discovery: an overview. Royal Society of Chemistry Publishing; 2006. p. 219-50
   Google Scholar
• Wyeth, assignee. Hydroxy-biphenyl-carbaldehyde oxime derivatives and their use as estrogenic agents. WO2004099122; 2004
   Google Scholar
• Yang C, Edsall R Jr, Harris HA, ERbeta ligands. Part 2: synthesis and structure-activity relationships of a series of 4-hydroxy-biphenyl-carbaldehyde oxime derivatives. Bioorg Med Chem 2004;12(10):2553-70
   PubMedGoogle Scholar
• Gutteridge JM, Quinlan GJ. Malondialdehyde formation from lipid peroxides in the thiobarbituric acid test: the role of lipid radicals, iron salts, and metal chelators. J Appl Biochem 1983;5(4-5):293-9
   PubMedGoogle Scholar
• Shughrue PJ, Lane MV, Merchenthaler I. Regulation of progesterone receptor messenger ribonucleic acid in the rat medial preoptic nucleus by estrogenic and antiestrogenic compounds: an in situ hybridization study. Endocrinology 1997;138(12):5476-84
   PubMedGoogle Scholar
• Merchenthaler I, Funkhouser JM, Carver JM, The effect of estrogens and antiestrogens in a rat model for hot flush. Maturitas 1998;30(3):307-16
   PubMedGoogle Scholar
• Cuzzocrea S, Santagati S, Sautebin L, 17beta-estradiol antiinflammatory activity in carrageenan-induced pleurisy. Endocrinology 2000;141(4):1455-63
   PubMedGoogle Scholar
• Zaulyanov LL, Green PS, Simpkins JW. Glutamate receptor requirement for neuronal death from anoxia-reoxygenation: an in Vitro model for assessment of the neuroprotective effects of estrogens. Cell Mol Neurobiol 1999;19(6):705-18
   PubMedGoogle Scholar
• Prokai L, Oon SM, Prokai-Tatrai K, Synthesis and biological evaluation of 17beta-alkoxyestra-1,3, 5(10)-trienes as potential neuroprotectants against oxidative stress. J Med Chem 2001;44(1):110-4
   PubMedGoogle Scholar
• Poole AR, Coombs RR. Rheumatoid-like joint lesions in rabbits injected intravenously with bovine serum. Int Arch Allergy Appl Immunol 1977;54(2):97-113
   PubMedGoogle Scholar
• Mankin HJ, Dorfman H, Lippiello L, Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data. J Bone Joint Surg Am 1971;53(3):523-37
   PubMed Web of Science ®Google Scholar
• Dubal DB, Shughrue PJ, Wilson ME, Estradiol modulates bcl-2 in cerebral ischemia: a potential role for estrogen receptors. J Neurosci 1999;19(15):6385-93
   PubMedGoogle Scholar
• Smirnoff P, Liel Y, Gnainsky J, The protective effect of estrogen against chemically induced murine colon carcinogenesis is associated with decreased CpG island methylation and increased mRNA and protein expression of the colonic vitamin D receptor. Oncol Res 1999;11(6):255-64
   PubMedGoogle Scholar
• Lundeen SG, Zhang Z, Zhu Y, Rat uterine complement C3 expression as a model for progesterone receptor modulators: characterization of the new progestin trimegestone. J Steroid Biochem Mol Biol 2001;78(2):137-43
   PubMedGoogle Scholar
• Wyeth, assignee. Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents. US7157491; 2007
   Google Scholar
• Vu AT, Campbell AN, Harris HA, ERbeta ligands. Part 6: 6H-Chromeno[4,3-b]quinolines as a new series of estrogen receptor beta-selective ligands. Bioorg Med Chem Lett 2007;17(14):4053-6
   PubMedGoogle Scholar
• Wyeth, assignee. (Hydroxyphenyl)-1H-indole- 3-carbaldehyde oxime derivatives as estrogenic agents. US20050059723; 2005
   Google Scholar
• Meyers MJ, Sun J, Carlson KE, Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues. J Med Chem 2001;44(24):4230-51
   PubMedGoogle Scholar
• Kilbourn MR, Arduengo AJ, Park JT, Katzenellenbogen JA. Conformational analysis of nonsteroidal estrogens: The effect of conformer populations on the binding affinity of meso- and dl-hexestrol to the estrogen receptor. Mol Pharmacol 1981;19(3):388-98
   PubMedGoogle Scholar
• Board of Trustees at the University of Illinois, assignee. Sulfonamides as selective estrogen receptor modulators. US20070021495; 2007
   Google Scholar
• Board of Trustees of the University of Illinois, assignee. Estrogen receptor ligands. WO200019994; 2000
   Google Scholar
• Coghlan RDF, Harris WF, Keith HA, , assignee. Phenyl substituted thiophenes as estrogenic agents. US6835745; 2004
   Google Scholar
• American Home Products Corporation, assignee. Bioassay for identifying estrogen receptor-beta/alpha selective modulators. WO2000037681; 2000
   Google Scholar
• Harris H, Henderson R, Bhat R, Komm B. Regulation of metallothionein II messenger ribonucleic acid measures exogenous estrogen receptor-beta activity in SAOS-2 and LNCaPLN3 cells. Endocrinology 2001;142(2):645-52
   PubMedGoogle Scholar
• Novo Nordisk A/S, assignee. Identification of ligands by selective amplification of cells transfected with receptors. US5707798; 1998
   Google Scholar
• Acadia Pharmaceuticals, Inc., assignee. Compounds with activity at estrogen receptor. US2005256210; 2005
   Google Scholar
• Stauffer SR, Coletta CJ, Tedesco R, Pyrazole ligands: structure-affinity/activity relationships and estrogen receptor-alpha-selective agonists. J Med Chem 2000;43(26):4934-47
   PubMedGoogle Scholar
• Harris HA, Katzenellenbogen JA, Katzenellenbogen BS. Characterization of the biological roles of the estrogen receptors, ERalpha and ERbeta, in estrogen target tissues in vivo through the use of an ERalpha-selective ligand. Endocrinology 2002;143(11):4172-7
   PubMedGoogle Scholar
• Gardell LR, Hyldtoft L, Del Tredici AL, Differential modulation of inflammatory pain by a selective estrogen receptor beta agonist. Eur J Pharmacol 2008;592(1-3):158-9
   PubMedGoogle Scholar
• Piu F, Cheevers C, Hyldtoft L, Broad modulation of neuropathic pain states by a selective estrogen receptor beta agonist. Eur J Pharmacol 2008;590(1-3):423-9
   PubMedGoogle Scholar
• Merck & Co., Inc., assignee. Estrogen receptor modulators. WO2002091993; 2002
   Google Scholar
• Blizzard TA, Morgan JD II, Mosley RT, 2-Phenylspiroindenes: a novel class of selective estrogen receptor modulators (SERMs). Bioorg Med Chem Lett 2003;13(3):479-83
   PubMedGoogle Scholar
• Muthyala RS, Sheng S, Carlson KE, Bridged bicyclic cores containing a 1,1-diarylethylene motif are high-affinity subtype-selective ligands for the estrogen receptor. J Med Chem 2003;46(9):1589-602
   PubMedGoogle Scholar
• Muthyala RS, Carlson KE, Katzenellenbogen JA. Exploration of the bicyclo[3.3.1]nonane system as a template for the development of new ligands for the estrogen receptor. Bioorg Med Chem Lett 2003;13(24):4485-8
   PubMedGoogle Scholar
• Zhou HB, Comninos JS, Stossi F, Synthesis and evaluation of estrogen receptor ligands with bridged oxabicyclic cores containing a diarylethylene motif: estrogen antagonists of unusual structure. J Med Chem 2005;48(23):7261-74
   PubMedGoogle Scholar
• Wyeth, assignee. Substituted indenones as estrogenic agents. US6903238; 2005
   Google Scholar
• Karo Bio AB, assignee. 2-Phenyl indene derivatives useful as estrogen receptor ligands. WO2008043567; 2008
   Google Scholar
• Wyeth, assignee. Substituted 2-phenyl benzofurans as estrogenic agents. Patent US6774248 (2004)
   Google Scholar
• Collini MD, Kaufman DH, Manas ES, 7-Substituted 2-phenyl-benzofurans as ER beta selective ligands. Bioorg Med. Chem Lett 2004;14(19):4925-9
   Google Scholar
• Astrazeneca AB, assignee. Therapeutic benzimidazole compounds. patent WO2002046168; 2002
   Google Scholar
• Astrazeneca AB, assignee. Therapeutic compounds. WO2002051821; 2002
   Google Scholar
• Wyeth, assignee. Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents. US6960607; 2005
   Google Scholar
• Wyeth, assignee. Substituted benzoxazoles as estrogenic agents. US6794403; 2004
   Google Scholar
• Wyeth, assignee. Prodrug substituted benzoxazoles as estrogenic agents. US20060046968; 2006
   Google Scholar
• Wyeth, assignee. Use of ER-beta selective ligands for treating acute lung injuries. US20080182872; 2008
   Google Scholar
• Leventhal L, Brandt MR, Cummons TA, An estrogen receptor-beta agonist is active in models of inflammatory and chemical-induced pain. Eur J Pharmacol 2006;553(1-3):146-8
   PubMedGoogle Scholar
• Follettie MT, Pinard M, Keith JC Jr, Organ messenger ribonucleic acid and plasma proteome changes in the adjuvant-induced arthritis model: responses to disease induction and therapy with the estrogen receptor-beta selective agonist ERB-041. Endocrinology 2006;147(2):714-23
   PubMedGoogle Scholar
• Malamas MS, Manas ES, McDevitt RE, Design and synthesis of aryl diphenolic azoles as potent and selective estrogen receptor-beta ligands. J Med Chem 2004;47(21):5021-40
   PubMedGoogle Scholar
• Pfizer, Inc., assignee. Benzimidazole compounds and their use as estrogen agonists/antagonists. US20040002524; 2004
   Google Scholar
• De Angelis M, Stossi F, Carlson KA, Indazole estrogens: highly selective ligands for the estrogen receptor beta. J Med Chem 2005;48(4):1132-44
   PubMedGoogle Scholar
• Japan Tobacco, Inc., assignee. Indole compounds and their medicinal use. JP2001122855; 2001
   Google Scholar
• Pfizer, Inc., assignee. Indole compounds and their use as estrogen agonists/antagonists. US20030220377; 2003
   Google Scholar
• Laboratoire Theramex, assignee. Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents. WO2006040351; 2006
   Google Scholar
• Eli Lilly and Company, assignee. Substituted benzopyrans as selective estrogen receptor-beta agonists. WO2004094401; 2004
   Google Scholar
• Akzo Nobel NV, assignee. Chroman derivatives as estrogenic compounds. US2003069303; 2003
   Google Scholar
• Bionovo, Inc., assignee. Composition for treatment of menopause. US20060222721; 2006
   Google Scholar
• Cvoro A, Paruthiyil S, Jones JO, Selective activation of estrogen receptor-beta transcriptional pathways by an herbal extract. Endocrinology 2007;148(2):538-47
   PubMedGoogle Scholar
• Stovall DW, Pinkerton JV. MF-101, an estrogen receptor beta agonist for the treatment of vasomotor symptoms in peri- and postmenopausal women. Curr Opin Investig Drugs 2009;10(4):365-71
   PubMedGoogle Scholar
• Grady D, Sawaya GF, Johnson KC, MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a Phase II clinical trial. Menopause 2009;16(3):458-65
   Google Scholar
• Powell E, Xu W. Intermolecular interactions identify ligand-selective activity of estrogen receptor alpha/beta dimers. Proc Natl Acad Sci USA 2008;105(48):19012-7
   PubMedGoogle Scholar
• Mersereau JE, Levy N, Staub RE, Liquiritigenin is a plant-derived highly selective estrogen receptor beta agonist. Mol Cell Endocrinol 2008;283(1-2):49-57
   PubMedGoogle Scholar
• Bionovo, Inc., assignee. Liquiritigenin and derivatives as selective estrogen receptor beta agonists. WO2009002802; 2009
   Google Scholar
• Bionovo, Inc., assignee. Estrogenic extracts of Asparagus conchinchinensis (lour.) merr of the Lilliaceae family and uses thereof. WO2009033025; 2009
   Google Scholar
• Bionovo, Inc., assignee. Estrogenic extracts of Astragalus membranaceus Fisch.bge.var.mongolicus bge of the Leguminosae family and uses thereof. WO2009033099; 2009
   Google Scholar
• Bionovo, Inc., assignee. Estrogenic extracts of Ligustrum lucidum and uses thereof. WO2009021196; 2009
   Google Scholar
• Bionovo, Inc., assignee. Estrogenic extracts of Pueraria lobata willd, ohwi of the Leguminosae family and uses thereof. WO2009033103; 2009
   Google Scholar
• Bionovo, Inc., assignee. Estrogenic extracts of Rheum palmatum L. of the Polyganaceae family and uses thereof. WO2009033105; 2009
   Google Scholar
• Bionovo, Inc., assignee. Estrogenic extracts of Scuttelaria barbata D. don of the Labiatae family and uses thereof. WO2009033075; 2009
   Google Scholar
• Universiteit Gent, assignee. Naringenin derivatives with selectivity on ERs. WO2007053915; 2007
   Google Scholar
• Children's Hospital Medical Center (Cincinnati, OH) and Australian Health & Nutrition Assoc. Ltd (New South Wales, Australia), assignee. Compositions and products contining S-equol, and methods for their making. US7396855; 2008
   Google Scholar
• Girindus America, Inc. (Cincinnati, OH) and Children's Hospital Medical Center (Cincinnati, OH), assignee. Method for enantioselective hydrogenation of chromenes. US7528267; 2009
   Google Scholar
• Signal Pharmaceuticals, Inc., assignee. Compounds and methods for modulation of estrogen receptors. US6686351; 2004
   Google Scholar
• AstraZeneca AB, assignee. Selective estrogen receptor-beta ligands. US7256201; 2007
   Google Scholar
• Bristol-Myers Squibb Company, assignee. 3-Arylquinazolinone derivatives as selective estrogen receptor beta modulators. US7381730; 2008
   Google Scholar
• Bristol-Myers Squibb Company, assignee. C5-substituted quinazolinone derivatives as selective estrogen receptor beta modulators. WO2006116401; 2006
   Google Scholar
• Gungor T, Chen Y, Golla R, Synthesis and characterization of 3-arylquinazolinone and 3-arylquinazolinethione derivatives as selective estrogen receptor beta modulators. J Med Chem 2006;49(8):2440-55
   PubMedGoogle Scholar
• Bristol-Myers Squibb Company, assignee. 3-Aryl-hydoxybenzoxazines and 3,4-dihydro-3-arylbenzoxazines as selective estrogen receptor beta modulators. US7015219; 2006
   Google Scholar
• Yang W, Wang Y, Ma Z, Synthesis and structure-activity relationship of 3-arylbenzoxazines as selective estrogen receptor beta agonists. Bioorg Med Chem Lett 2004;14(9):2327-30
   PubMedGoogle Scholar
• Wyeth, assignee. Phenyl quinolines and their use as estrogenic agents. US20050009784; 2005
   Google Scholar
• Wyeth, assignee. Substituted phenyl naphthalenes as estrogenic agents. US6914074; 2005
   Google Scholar
• Aventis Pharmaceutical, Inc., assignee. Use of certain phenyl-naphthyl compounds that do not have significant affinity to ER alpha or ER beta for protection of neurons and oligodendrocytes in the treatment of multiple sclerosis. US20070225330; 2007
   Google Scholar
• GTx, Inc., assignee. Nuclear receptor binding agents. WO2008091555; 2008
   Google Scholar
• Richardson TI, Dodge JA, Wang Y, Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 5: combined A- and C-ring structure-activity relationship studies. Bioorg Med. Chem Lett 2007;17(20):5563-6
   Google Scholar
• Richardson TI, Dodge JA, Durst GL, Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 3: synthesis of cyclopentanone and cyclohexanone intermediates for C-ring modification. Bioorg Med Chem Lett 2007;17(17):4824-8
   PubMedGoogle Scholar
• Norman BH, Richardson TI, Dodge JA, Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 4: functionalization of the benzopyran A-ring. Bioorg Med Chem Lett 2007;17(18):5082-5
   PubMedGoogle Scholar
• Eli Lilly and Company, assignee. Substituted benzopyrans as selective estrogen receptor beta agonists. US6630508; 2003
   Google Scholar
• Eli Lilly and Company, assignee. Substituted benzopyrans as selective estrogen receptor- beta agonists. WO2004094400; 2004
   Google Scholar
• Eli Lilly and Company, assignee. Substituted benzopyrans as selective estrogen receptor-beta agonists. US7279499; 2007
   Google Scholar
• Perlmutter MA, Lepor H. Androgen deprivation therapy in the treatment of advanced prostate cancer. Rev Urol 2007;9(Suppl 1):S3-8
   Google Scholar
• Eli Lilly and Company, assignee. Substituted tetralins as selective estrogen receptor-beta agonists. WO2006088716; 2006
   Google Scholar
• Wilkening RR, Ratcliffe RW, Tynebor EC, The discovery of tetrahydrofluorenones as a new class of estrogen receptor beta-subtype selective ligands. Bioorg Med Chem Lett 2006;16(13):3489-94
   PubMedGoogle Scholar
• Wilkening RR, Ratcliffe RW, Fried AK, Estrogen receptor beta-subtype selective tetrahydrofluorenones: use of a fused pyrazole as a phenol bioisostere. Bioorg Med. Chem Lett 2006;16(15):3896-901
   Google Scholar
• Parker DL, Jr., Meng D, Triazolo-tetrahydrofluorenones as selective estrogen receptor beta agonists. Bioorg Med Chem Lett 2006;16(17):4652-6
   PubMedGoogle Scholar
• Merck & Co., Inc., assignee. ER modulators. US7157604; 2007
   Google Scholar
• Merck & Co., Inc., assignee. Estrogen receptor modulators. US7087599; 2006
   Google Scholar
• Merck & Co., Inc., assignee. ERM's. WO2002041835; 2002
   Google Scholar
• Merck & Co., Inc., assignee. Modulators of the estrogen receptor. WO2006062876; 2006
   Google Scholar
• Merck & Co., Inc., assignee. Modulators of ER. WO2007089291; 2007
   Google Scholar
• Merck & Co., Inc., assignee. ER modulators. US7151196; 2006
   Google Scholar
• Merck, assignee. Pyranoflavonoid compounds and their use as estrogen receptor modulators. WO2002058639; 2002
   Google Scholar
• Wyeth, assignee. Dibenzo chromene derivatives and their use as ERbeta selective ligands. US7157492; 2007
   Google Scholar
• Wyeth, assignee. Substituted 6H-dibenzo[c,h]chromenes as estrogenic agents. WO2003051863; 2003
   Google Scholar
• Wyeth, assignee. 6H-[1]benzopyraro[4,3-b]quinolines and their use as estrogenic agents. US20060052410; 2006
   Google Scholar
• Wyeth, assignee. Tetracyclic compounds as estrogenic ligands. US20060004087; 2006
   Google Scholar
• Paruthiyil S, Cvoro A, Zhao X, Drug and cell type-specific regulation of genes with different classes of estrogen receptor beta-selective agonists. PLoS One 2009;4(7):e6271
   Google Scholar
• Nilsson S, Kuiper G, Gustafsson JA. ERbeta a novel estrogen receptor offers the potential for new drug development. Trends Endocrinol Metab 1998;9(10):387-95
   PubMedGoogle Scholar
• Pike AC, Brzozowski AM, Hubbard RE, Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. Embo J 1999;18(17):4608-18
   PubMedGoogle Scholar
• Edsall RJ Jr, Harris HA, Manas ES, Mewshaw RE. ERbeta ligands. Part 1: the discovery of ERbeta selective ligands which embrace the 4-hydroxy-biphenyl template. Bioorg Med Chem 2003;11(16):3457-74
   PubMedGoogle Scholar
• Vu AT, Cohn ST, Manas ES, ERbeta ligands. Part 4: Synthesis and structure-activity relationships of a series of 2-phenylquinoline derivatives. Bioorg Med Chem Lett 2005;15(20):4520-5
   PubMedGoogle Scholar
• McDevitt RE, Malamas MS, Manas ES, Estrogen receptor ligands: design and synthesis of new 2-arylindene-1-ones. Bioorg Med Chem Lett 2005;15(12):3137-42
   PubMedGoogle Scholar
• Manas ES, Unwalla RJ, Xu ZB, Structure-based design of estrogen receptor-beta selective ligands. J Am Chem Soc 2004;126(46):15106-19
   PubMedGoogle Scholar
• Richardson TI, Norman BH, Lugar CW, Benzopyrans as selective estrogen receptor beta agonists (SERBAs). Part 2: structure-activity relationship studies on the benzopyran scaffold. Bioorg Med Chem Lett 2007;17(13):3570-4
   PubMedGoogle Scholar
• Chesworth R, Wessel MD, Heyden L, Estrogen receptor beta selective ligands: discovery and SAR of novel heterocyclic ligands. Bioorg Med Chem Lett 2005;15(24):5562-6
   PubMedGoogle Scholar
• Schopfer U, Schoeffter P, Bischoff SF, Toward selective ERbeta agonists for central nervous system disorders: synthesis and characterization of aryl benzthiophenes. J Med Chem 2002;45(7):1399-401
   PubMedGoogle Scholar
• De Angelis M, Stossi F, Waibel M, Isocoumarins as estrogen receptor beta selective ligands: Isomers of isoflavone phytoestrogens and their metabolites. Bioorg Med Chem 2005;13(23):6529-42
   PubMedGoogle Scholar
• Blizzard TA, Gude C, Chan W, Bridged androstenediol analogs as ER-beta selective SERMs. Bioorg Med Chem Lett 2007;17(10):2944-8
   PubMedGoogle Scholar
• Blizzard TA, Gude C, Morgan JD II, Androstene-3,5-dienes as ER-beta selective SERMs. Bioorg Med Chem Lett 2007;17(22):6295-8
   PubMedGoogle Scholar
• Blizzard TA, Gude C, Morgan JD II, Androstenediol analogs as ER-beta-selective SERMs. Bioorg Med Chem Lett 2006;16(4):834-8
   PubMedGoogle Scholar
• Sun W, Cama LD, Birzin ET, 6H-Benzo[c]chromen-6-one derivatives as selective ERbeta agonists. Bioorg Med Chem Lett 2006;16(6):1468-72
   PubMedGoogle Scholar
• Harris HA. The unexpected science of estrogen receptor-beta selective agonists: a new class of anti-inflammatory agents? Nucl Recept Signal 2006;4:e012
   Google Scholar
• Walf AA, Koonce CJ, Frye CA. Estradiol or diarylpropionitrile decrease anxiety-like behavior of wildtype, but not estrogen receptor beta knockout, mice. Behav Neurosci 2008;122(5):974-81
   PubMedGoogle Scholar
• Walf AA, Koonce CJ, Frye CA. Adult female wildtype, but not oestrogen receptor beta knockout, mice have decreased depression-like behaviour during pro-oestrus and following administration of oestradiol or diarylpropionitrile. J Psychopharmacol 2009;23(4):442-50
   PubMedGoogle Scholar
• Motylewska E, Stasikowska O, Melen-Mucha G. The inhibitory effect of diarylpropionitrile, a selective agonist of estrogen receptor beta, on the growth of MC38 colon cancer line. Cancer Lett 2009;276(1):68-73
   PubMedGoogle Scholar
• McCarty MF, Barroso-Aranda J, Contreras F. Genistein and phycocyanobilin may prevent hepatic fibrosis by suppressing proliferation and activation of hepatic stellate cells. Med Hypotheses 2009;72(3):330-2
   PubMedGoogle Scholar
• Liu F, Day M, Muniz LC, Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory. Nat Neurosci 2008;11(3):334-43
   PubMedGoogle Scholar
• Meltser I, Tahera Y, Simpson E, Estrogen receptor beta protects against acoustic trauma in mice. J Clin Invest 2008;118(4):1563-70
   PubMedGoogle Scholar
• Merlo S, Frasca G, Canonico PL, Sortino MA. Differential involvement of estrogen receptor alpha and estrogen receptor beta in the healing promoting effect of estrogen in human keratinocytes. J Endocrinol 2009;200(2):189-97
   PubMedGoogle Scholar